Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

Horse Flu Vaccine Application Approved By ERMA

Media Release 21 DECEMBER 2007

Authority Approves Application To Bring In Horse Flu Vaccine

The Environmental Risk Management Authority (ERMA New Zealand) has approved an application by the Ministry of Agriculture and Forestry Biosecurity New Zealand (MAF BNZ) to use a vaccine to protect New Zealand horses against the equine influenza virus.

The equine influenza virus caused major disruption in the horse racing and breeding industry in Australia earlier this year after infected animals were discovered in New South Wales. Thousands of horses eventually tested positive for the virus. Australia has since imported a vaccine to help control the disease.

The use of the Flu Avert I.N vaccine in the event of equine influenza being identified in horses in New Zealand has been approved with a number of conditions placed on its use.

ERMA New Zealand's General Manager, New Organisms, Dr Libby Harrison, says in approving the vaccine the Authority's decision-making committee considered potential adverse effects on public safety and health, valued species, societies and communities, the economy, the environment and natural habitats. "The Committee decided that the risks posed by the vaccine are negligible. However, in recognition of the risks, the committee has imposed conditions on storage, handling and use of the vaccine."

The conditions placed on the vaccine include:

Only approved veterinarians will be able to receive and administer the
vaccine;
Vaccinated horses must be kept separate from unvaccinated horses for a
period of 14 days after vaccination; and
MAF BNZ will keep a register of vaccine importations, approved vets, and
horses that have been vaccinated.

Dr Harrison says the approval of this vaccine gives MAF an additional tool for use in case of an outbreak of equine influenza in New Zealand. The Flu Avert I.N vaccine contains a weakened live equine influenza virus which is administered to horses via the nose. It stimulates an immune response that is similar to the response that occurs when the horse catches a virulent wild strain of the virus. The vaccine still has to be approved by the New Zealand Food Safety Authority's Agricultural Compounds and Veterinary Medicines Group before it can be used.

ENDS


© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Real Estate: Foreign Buyers Ban Passes Third Reading

The Bill to put in place the Government’s policy of banning overseas buyers of existing homes has passed its third and final reading in the House. More>>

ALSO:

Nine Merger: Fairfax Slashes Value Of NZ Business

Fairfax Media Group more than halved the value of its Kiwi assets, attaching just A$40 million to mastheads that were once the core of a billion dollar investment. More>>

Collecting Scalpers: Commerce Commission To Sue Viagogo

The Commission will claim that Viagogo made false or misleading representations: • that it was an “official” seller, when it was not • that tickets were limited or about to sell out • that consumers were “guaranteed” to receive valid tickets for their event • about the price of tickets... More>>

ALSO:

Price Of Cheese: Fonterra CEO Goes Early After Milk Price Trimmed

Aug. 15 (BusinessDesk) - Fonterra Cooperative Group chief executive Theo Spierings is leaving the role early after the world's biggest dairy exporter lowered its farmgate payout and trimmed its dividend to retain cash. More>>

ALSO: